Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/02—Prostheses implantable into the body
  • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
  • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
  • A61F2/2418—Scaffolds therefor, e.g. support stents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
  • A61F2/02—Prostheses implantable into the body
  • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
  • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
  • A61F2/2415—Manufacturing methods
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
  • A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
  • A61F2220/0066—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements stapled

Definitions

• the present invention relates to the field of medicine, in particular of reconstructive surgery, and in particular of cardiac surgery, more particularly of cardiac prostheses, and relates to a valve endoprosthesis.
• the human heart functions as a pulsed pump, whose main function is to create a blood circulation in the veins and arteries, to bring oxygen and various nutrients to the organs of the body that need them.
• it is essential that there is no blood reflux, that is to say that the blood does not come back during the non-depressing phases or relaxation of the muscle heart.
• the latter is equipped with heart valves which act as a non-return valve.
• these valves can become deficient with the years and need to be replaced by prostheses, which do not yet fully respect the very complex physiology of the individual.
• Implantation of aortic heart valve prostheses is generally necessary to overcome deficiencies due to the degeneration of said aortic valve, more particularly for reasons of calcification of the valve tissue due to abnormal tissue impregnation with calcium salts following a degeneration of the collagen fibers, which constitute said tissue.
• These lips forming the valve are in fact subjected to a continuous movement of opening and closing of the aorta at a speed corresponding to the heart rate, so that any stiffening of the fabric constituting irretrievably leads to an accelerated fatigue wear.
• This wear of the heart valve will have two types of consequences, namely a valve symphysis creating aortic stenosis responsible for an obstacle to the ejection of the left ventricle and a destruction of the valves creating a diastolic reflux to the left ventricle. Both of these effects lead to heart failure.
• the patient then suffers from a stenosis, namely a partial closure or a narrowing of the aortic duct, due to the fact that the complete opening of the valve is prevented.
• a pathology develops rather in elderly subjects.
• a particular physiological reaction resides in the formation of blood clots, or thrombosis, which is the result of platelet fibrino deposition on the diseased areas.
• Such clots prevent the movement of valvular leaflets, which no longer allow complete closure of the valve, leading to aortic insufficiency or valve leakage.
• the first methods used to construct mechanical prosthetic valves consisted of producing them, either in the form of a ball of biocompatible material housed in a retaining cage simultaneously forming a tight seat on the side facing the cardiac muscle, or under form of one or two disks hinged to a frame, these valves being mounted at the exit of the heart muscle, in the end of the artery comprising the sinews of reflux of the blood flow during the closure of the valve.
• bioprostheses which are a common solution for the replacement of deficient natural valves, respect the human physiology by allowing a central flow and are generally very well supported in transplant by offering the patient a good quality of life, while avoiding him the taking of 'anti coagulants.
• valve prostheses made of synthetic material, in particular polyurethane or silicone formed.
• these valves have fatigue strength problems with the risk of rupture in the bending zones.
• EP-AI 499 266 discloses a method for producing a prosthetic aortic or mitral valve which essentially consists in producing said prosthesis by shaping a textile material.
• a prosthesis makes it possible to avoid taking anticoagulants (geometry that reproduces that of the native valve) while avoiding the degeneration specific to the biological tissue. It has a perfect biocompatibility and excellent resistance to aging.
• specialists have set a short-term goal of widespread replacement of the aortic valve percutaneously. To date, such a procedure is still only at an experimental stage, with only a hundred implantations having been carried out in the world, and no significant decline exists.
• the challenge of the new procedure lies in a non-invasive surgery avoiding a heavy operation for the patient, namely an opening of the thorax and a stop of the heart, as is the case during implantation.
• classic heart valve a heavy operation for the patient
• the replacement of the aortic valve will concern a growing number of elderly people, and therefore a population at risk.
• the cost associated with the replacement of a valve is consequent, because of the infrastructure related to the operation itself and the necessary rehabilitation of the patient.
• a first implantation of a percutaneous biological valve prosthesis was therefore performed in 2002 and has since been followed by approximately one hundred other implantations.
• the biological valve is associated with a conventional cylindrical arterial stent or expandable framework.
• the term stent will only be used.
• Valve stents are currently essentially tubular and reproduce the geometry of arterial stents and can be classified into three categories of devices, namely short tube, medium tube and long tube.
• the short tube devices are essentially of two types of implementation, namely positioning with a large radial force and by means of hooks or setting in position by inflation and injection of polymer.
• the technique of positioning is perfectly controlled, but this positioning is random at the height of the aortic ring and the radial force is degrading to the tissues.
• angular positioning is not feasible, the seal is dependent on the radial force and there is a high risk of migration.
• inflation positioning the geometry of the aortic root is perfectly matched, so that the seal is ensured.
• this procedure is not degrading for the valve nor for fabrics.
• positioning is also random at the level of the aortic annulus, the angular positioning is also not ensured and there is a partial closure of the sinuses.
• the medium tube devices are also of two types of implementation, one by positioning with a large radial force, with a long stent and hooks and the other by setting in position by pinching the native valve.
• the positioning technique is perfectly controlled and the positioning is done by the length of the stent.
• the radial force is degrading for the tissues, the tightness is dependent on the radial force, and there is a risk of migration.
• angular positioning is not possible.
• the positioning is effected by the length of the stent, and in an angularly defined manner, the risk of migration being avoided.
• the radial and pinch force is degrading to the tissues, resulting in a seal entirely dependent on this effort.
• Long tube devices are generally positioned with a large radial force and taking advantage of the length of the stent and have the advantage of avoiding the risk of migration and proper positioning due to the length of the stent.
• Some of these devices allow, in addition, angular positioning in the sinuses.
• the disadvantage of a degrading radial force for tissue may be negative with respect to sealing.
• the implementation of hooks is traumatic for biological tissues, which can suffer, due to the large radial force, harmful degradation to a good functioning of the prosthesis over time.
• Another device has also been developed and is put in position by the length of the stent and with an obstacle in the sinuses.
• This device allows a good positioning, because of the length of the stent, and avoids a risk of migration thanks to the obstacle in the sinuses, while guaranteeing the angular positioning in the sinuses and the reforming of these latter.
• this device does not constitute an annoyance of the mitral valve.
• WO-A-2005/046528 discloses a valve endoprosthesis, the lower part of which has a flared shape. This geometry is characterized by a gradual increase in the diameter of the lower body of the device towards its lower end.
• the support of the flared bottom portion in the natural conduit is achieved by means of a nip in the aortic sinuses.
• the sinuses are composed of highly deformable elastic tissues and the support of the lower part flared on them is limited to a line of contact, which induces high stress concentrations. The sinuses are therefore locally and strongly deformed which may induce a disruption of blood flow. This anchoring mode does not respect the aortic environment.
• the contact with the wall of the aortic sinuses is reduced to a discontinuous line of contact, does not allow to ensure the tightness of the device, because it does not accommodate to the imperfections of the aortic ring.
• EP-A-1 690 515 describes a device provided with arches extending outwardly with respect to its diameter, against the walls of the aortic sinuses, thus ensuring the positioning of the valve stent. These arches must ensure contact with the sinus wall, to ensure the anchorage of the valve stent and not to disturb the blood flow. Since the aortic sinuses are subject to variations in size during the cardiac cycle, the valve stent must therefore accommodate these dimensional variations, in order to ensure in any case the contact of the arches on the sinus wall. However, such flexibility, in order to respect the morphological variations of the aortic sinuses, is not provided for in this document.
• the present invention aims to overcome the disadvantages of the new stents described above by providing a valve stent allowing, on the one hand, a percutaneous implantation and, on the other hand, to overcome the problems of degradation of the prosthetic material and human tissue, as well as to ensure the sealing of the device, while ensuring the maintenance in position on the implantation site and the operation of the implanted valvular prosthesis.
• valve endoprosthesis is characterized in that it consists essentially of a stent or expandable reinforcement, consisting of several parts, namely an upper cylinder, a lower frustoconical support portion, whose maximum diameter is greater than that of the aortic annulus and decreases to reach the diameter of the stent or expandable armature towards the proximal end, and arches, the upper cylinder being connected to the lower abutment via of uprights, and by a valve connected to said stent by suture, staples or clips.
• FIG. schematic perspective view of the stent according to the invention is a side elevational view of the stent or expandable frame of the stent according to Figure 1, without the textile valve;
• Figure 3 is a schematic top view of the stent according to Figure 1;
• Figures 4a and 4b are partial perspective views showing the connecting posts from the upper part of the stent to its conical lower part;
• Figures 5a to 5d show the successive configurations of the textile valve for mounting on the conical lower portion of the stent, and
• Figure 6 shows the stent in the compressed position before placement.
• FIG. 1 of the accompanying drawings shows a cardiac valve stent for percutaneous implantation.
• this valve endoprosthesis essentially consists of a stent or extensible armature 1, preferably consisting of several parts, namely an upper cylinder 11, a lower support portion 21 of frustoconical shape, whose maximum diameter is greater than to that of the aortic ring and decreases to reach the diameter of the stent 1 or extensible armature towards the proximal end, and the arches 31, the upper cylinder 11 being connected to the lower bearing portion 21 by the intermediate amounts 41, and a valve 2 connected to said stent 1 by suture, staples, clips or other.
• the proximal end of the lower bearing portion 21 forms a partially spherical or toric surface.
• the lower support portion 21 thus has a gradual decrease in the diameter of the lower body towards its lower end thus providing a contact surface and not a nip. This contact surface is supported on the aortic ring and not in the sinuses, which are not affected by the support of the conical lower part
• the arches 31 are connected to the upper cylinder 11 and advantageously extend outwardly with respect to the diameter of the latter.
• the arches 31 can be flexible and can follow the deformation of the sinuses during the cardiac cycle, so as not to stiffen the sinuses and minimize the stress on the tissues.
• arches 31 on another part of the stent 1 or extensible armature, namely in the upper part or in the lower part thereof, or on the uprights 41.
• all solutions derived are possible, both that accommodation of the arches 31 to the sinus is possible, both in static, or in a non-ideal morphology of the aortic root, than in dynamics, namely during the cardiac cycle.
• the arches 31 have a curved shape such that they respect the native shape of the sinuses, both by their geometry and by their bearing surface, which distribute the stresses and thus allow not to deform the tissues locally.
• This configuration of the arches 31 also makes it possible to avoid the obstruction of the coronal orifices, for example by a purified, dimpled, minimal support surface.
• the stent according to the invention is thus perfectly suited to implantation in natural ducts presenting an aneurysm around the valve, such as the aortic root with the sinus of Valsalva, the arches then deploying in the bulges formed by the sinuses.
• the upper cylinder 11 is intended to perform a positioning of the stent in the aorta and sinuses, in cooperation with the arches 31, while the lower support portion 21 is applied on the support of the aortic ring.
• the amounts 41 are, for their part, intended to achieve the connection between the upper cylinder 11 provided with the arches 31 and the lower bearing portion 21, while providing a support function of the valve 2.
• the positioning of the stent according to the invention is ensured by the obstacles that form, on the one hand, the lower support portion 21, whose proximal end forms a partially spherical or toric surface and, d on the other hand, the arches 31 and not, as in the stents proposed to date, by adhesion, so that the radial force is reduced and is therefore atraumatic for tissues.
• the main support is on the aortic ring and not in the sinuses.
• the upper cylinder 11 and the lower support portion 21 of frustoconical shape are made by braiding and the arches 31 are also made by braiding and sutured to the upper cylinder 11 forming excrescences with respect to the latter.
• the braided structure of the upper cylinder 11 and the lower part 21 allow easy elastic expansion, in the manner of a grid, so that the stent 1 obtained is more flexible than if it were made of a solid material, machined .
• the different parts of the stent or expandable armature 1 may be more or less independent, that is to say be manufactured alone or in blocks. In addition, these different parts could also be obtained by machining, knitting or other.
• the arches 31 are three in number and are arranged at regular intervals in the lower part of the upper cylinder 11.
• stent 1 is specifically adapted to the morphology of the aortic root, in which the device will be implanted.
• stent or extensible armature 1 in one piece of metal alloy, braided or machined Nitinol type, obtained by prior cutting and forming.
• the stent 1 is made from a cylindrical or slightly conical blank, in which are cut the legs at the height of the arches, which are then connected to the whole at their upper part.
• the curved geometry of the arches is then obtained by a new shaping.
• the amounts consist of the remainder of material remaining on either side of the cutouts and are in continuity with the upper cylinder and the conical base.
• FIG. 6 of the attached drawings shows a stent 1 in its compressed position before placement, in which the arches 31 are in a folded position very close to the cylindrical space of the rest of the stent 1.
• These arches 31 are positioned, during the expansion of the stent 1 in its position shown in Figures 1 to 4, by oblique expansion in the aortic sinuses.
• the sinuses which consist of three pockets located behind the valvular leaflets in the manner of three growths of the aortic tube, form receiving receptacles arches 31.
• These sinuses participate in the closure mechanism of the valve from the point of view fluid dynamics and provide axial bilaterality, parallel to the lower support portion 21, constituting three axial support points for the arches 31.
• the stent 1 or extensible armature is, because of its constitution and the assembly of its various components, compressible, which represents a considerable advantage in terms of its percutaneous implantation capabilities.
• the assembly of the various components makes it possible to obtain a constant length of the stent 1 in its expanded and compressed states.
• the length of the compressed stent is not increased, which facilitates its passage through the natural channels and, on the other hand, the positioning by medical imaging of the stent on the site. implantation is facilitated since the final length is equivalent to the extended length of the stent 1.
• the valve 2 is preferably constituted by a fabric textile membrane, nonwoven in the form of assembled fibers or nonwoven obtained by autofibrillation of a membrane by drawing and knitting and whose shaping is carried out by concentric stamping, three-dimensional weaving, flat stamping, clipping and fixing, and optionally, thermofixation, prior mechanical deformation and application, at the level of the deformations, of a heat-transfer fluid, by application to a counter-form by a suction effect through said counter-form and thermo-fixing by a supply of air or a hot gas sucked through the textile membrane in the counter-form or heat transfer fluid plating the textile membrane against a counter-form.
• the constitution and the shaping of a textile valve comparable to the textile valve 2 are described in EP-AI 499 266.
• valve 2 may also be made of another flexible material, namely biological, synthetic or metallic.
• the valve 2, shown more particularly in FIGS. 5a to 5d, is advantageously shaped identically to the aortic valve and is provided, on the one hand, with lips 2 'and, on the other hand, with a circular skirt 2 " , this circular skirt 2 "carrying the lips 2 'at its upper part and being folded, in the manner of a conical cup 2'", in a portion of a sphere or in a portion of a torus, along a fold line 2 "" ( Figure 5d).
• the valve 2 is connected to the lower support part 21 of the stent 1 by interlocking from below on said lower support portion 21, folding its rim inside the edge of said lower support portion 21 and assembly therewith by suture, staples, clips or other ( Figures 1 and 3). It is also possible not to provide a folding of the flange of the valve inside the edge of the lower support portion of the stent 1, for example to limit congestion in the catheter and further improve the compressibility of the part lower support of the stent 1.
• the amounts 41 are secured to the lower support part 21 and the valve 2, by pressing on the folded flange inside the lower support part 21, via tabs 41 '. laterally projecting obliquely upwards, and by suture, staples, clips or other on the lower portion of support assembly 21 and valve 2. These amounts 41 are fixed at their upper end, inside the However, according to an alternative embodiment, the uprights 41 can also be fixed outside the upper cylinder 11. It is thus possible, by this attachment of the uprights 41, to obtain a stent 1, whose compression is not impeded and which can be compressed without increasing its length. According to a variant of the invention, the uprights 41 may also be in one piece with the lower support portion 21, by manufacturing in a single unit with the latter. Furthermore, the amounts 41 may be flexible or rigid and any material, namely metallic or synthetic.
• the uprights 41 may have a particular surface avoiding the sliding of the valve 2, namely holes, an interlacing strands forming a scale, texturing. or else a cladding with a textile material or other.
• a particular surface avoiding the sliding of the valve 2 namely holes, an interlacing strands forming a scale, texturing. or else a cladding with a textile material or other.
• These amounts 41 allow in the first place to associate the top and bottom of the stent 1. In addition, these amounts 41 can support the commissures of the prosthetic valve and thus ensure the operation by reducing the effort applied to commissures in systole.
• a certain flexibility / flexibility of the uprights 41 can be useful for the operation of the prosthetic valve by allowing deformation by curvature, so that in the presence of an aorta of dimension greater than that of the aortic ring, the amounts 41 have a curvature tending to move their upper end outwardly relative to the lower bearing portion 21, while in the opposite case, this curvature will have the effect of bringing the upper end of said uprights 41 inwards by relative to said lower support portion 21.
• the deployment of the upper cylinder 11 in the aorta provides axial guidance of the stent.
• the arches 31 provide, on the one hand, by their expansion in the upper part of the sinuses, an angular positioning of the stent and, on the other hand, the axial positioning in the aortic root by pressing the lower support part 21 on the aortic ring.
• the amounts 41 are advantageously three in number, arranged equidistantly around the periphery of the lower support portion 21.
• the amounts 41 ensuring the attachment of the valve 2 extend inside the upper cylinder 11 possibly without guiding contact with the inner wall of the latter, while the three amounts ensuring the attachment of the valve 2 can be flexible or rigid.
• the uprights 41 may be integrated by their lower end directly into the valve 2, during the manufacture of the latter, in the form of wire or the like, thereby producing a textile composite.
• Such an embodiment is particularly advantageous for the interchangeability of the valve 2 in case of degradation of the latter, without removing the upper cylinder 11 of the stent 1.
• the lower support portion 21 bears on the aortic ring or base of the aortic root by a large contact surface similar to the deformation of a flexible cone under the pressure of a ball, that is to say with a circular or substantially circular circular contact or sphere segment.
• This part 21 constitutes the main support zone and its holding in position does not require radial force which would consist of a strong stress on the tissues, as is the case with the devices known to date.
• the stent 1 has a lower bearing portion 21 which ensures the proximal anchoring of the stent on the aortic ring without the need to exert a radial force.
• the stent acts as an obstacle in the aortic root and can not move.
• this lower support portion 21 seals by wedging the conical cup 2 '", in a sphere portion or toroidal portion of the valve 2 between the lower braided support portion 21 of the stent 1 and the aortic annulus.It also exerts a radial force on the tissue, for example, to maintain the conical shape, to ensure optimal opening of the valvular canal and to overcome calcifications.
• This lower bearing portion 21 may also have some flexibility to respect the compliance of the aortic annulus, for example to follow the dilation of the aortic annulus during the cardiac cycle, in order to minimize the trauma of the tissues and tissues. ensure permanent contact with the ring.
• the upper cylinder 11 and the lower support part 21, as well as the arches 31 of the stent 1 are advantageously made by intercrossing of metal son.
• These metal wires may be simple metal wires or metal wires made of a shape memory material.
• the entire stent has a high flexibility promoting its implantation in a mostly degraded environment, including calcified and non-regular.
• the metal son constituting the upper cylinder 11 and the lower support portion 21, and the arches 31 of the stent 1 may be made of the same material or in different materials.
• the stent 1 consists of independent elements, different materials can be envisaged for each constituent part in order to optimize the mechanical properties of each function.
• This concept of intersecting metal son allows, in the case of implementation of a textile valve itself made by a crisscrossing of son, obtaining a homogeneous whole very little exposed to wear, wear of the textile valve 2 on the lower support portion 21 being reduced, because there is a very low concentration of stress, compared to the implementation of a machined support, on which the textile valve 2 would be fixed.
• this cylinder 1 1 forming the upper part of the stent 1 may be made of a material different from that constituting the lower support portion 21 and the arches 31 and be connected thereto, as well as to the uprights 41, d on the one hand, by bonding or welding said upright 41 on its inner wall and the end of the arches 31 on its lower end, the uprights 41 being connected by their lower end, by suture, by gluing or by welding, to the lower support part 21.
• the constitution in several elements of the stent 1 allows, moreover, facilitated interchangeability of the lower bearing portion 21 supporting the valve 2, in the case of a failure of the latter and therefore a new percutaneous operation, and the interchangeability of the other constituent elements of said stent, namely the upper cylinder 11, the arches 31 and the uprights 41.
• the invention it is possible to perform a cardiac valve stent, in which the stresses in the tissues of the aortic root are minimized, the impediment being provided by an obstacle, that is to say by the association of the stent 1 and the valve 2 sandwiched at the lower bearing portion 21 between the latter and the aortic ring, and not by implementing a significant radial force, this through a geometry resting on the aortic root and in combination with arches that ensure the bilaterality of the support, positioning itself in the sinuses.
• it can marry morphologies of different aortic roots, that is to say, different heights with less stress on the tissues.
• the flexible structure of the lower support portion 21, obtained by braiding, allows better adaptation to an aortic root, which may have irregularities.
• the stent according to the invention can be positioned overall atraumatically by the arches 31 positioned in the sines for radial and longitudinal positioning, while the lower support portion 21 provides longitudinal positioning on the ring. and that the upper cylinder 11 prevents tilting. It follows that supra-annular positioning is effected without interference of the mitral valve.
• the invention makes it possible to obtain an endoprosthesis associating two elements, namely a stent 1 and a valve 2, by suture, staples, clips or other to form a very homogeneous and very strong overall structure based on the intercrossing. of metal and synthetic threads.
• a stent comprising a textile valve also makes it possible to overcome the problems of degradation of the prosthetic material, problems essentially due to the prosthesis-metal interface, which may occur during compression of the device before implantation.
• the invention promotes a development of less expensive and less expensive surgical techniques, a percutaneous implantation by allowing a lighter intervention for the patient.

Landscapes

• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Cardiology (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Transplantation (AREA)
• Heart & Thoracic Surgery (AREA)
• Vascular Medicine (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Prostheses (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=39204638

Family Applications (1)

Country Status (6)

Families Citing this family (39)

Family Cites Families (8)

• 2007
  • 2007-08-09 FR FR0757012A patent/FR2919798B1/fr not_active Expired - Fee Related
• 2008
  • 2008-08-04 EP EP08827747A patent/EP2185106A2/fr not_active Withdrawn
  • 2008-08-04 US US12/733,155 patent/US20110153008A1/en not_active Abandoned
  • 2008-08-04 CA CA2695873A patent/CA2695873A1/fr not_active Abandoned
  • 2008-08-04 WO PCT/FR2008/051456 patent/WO2009024716A2/fr not_active Ceased
  • 2008-08-04 JP JP2010519496A patent/JP2010535554A/ja active Pending

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events